Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0001012975-25-000812

Options or other derivatives

  • Chief Executive Officer acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Banks Jerel A. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-18 Grant or award : show line 1 in the form Options (right to buy) +450,000 450,000 D
Loading xslF345X05/form4.xml…